Technology
The Armonica platform overcomes the critical limitations of current NGS approachesand delivers key advantages over other long-read technologies.
Addresses the limitations of today’s sequencing technologies to advance the promise of precision medicine.
A fundamental issue for pore-based sequencing techniques is the speed of nucleic acid translocation. Our “tortuous nanopore” platform provides an elegant, inexpensive and manufacturable solution to this challenge.
Surface-enhanced Raman spectroscopy (SERS) readout provides direct structural information, enabling distinction of individual nucleotides and epigenetic marks.
Latest News
Armonica Technologies Awarded NIH Grant
Armonica Technologies, Inc., a biotechnology company developing a novel DNA sequencing system based on single molecule spectroscopy, announced that the company has been awarded a follow-on Phase II SBIR grant [...]